Leaderboard

En | De
No articles selected!     View Cart  
You are here: Urology-Nephrology » Neoplasia/BPH 28. May 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 9410  Previews Next
   
   Articles 1 - 20 / 188197  
   
Comparative analysis of genitourinary toxicity following bladder outlet obstruction procedures in patients before versus after radiotherapy for localized prostate cancer: a retrospective cohort study using the TriNetX database.
Prostate Cancer Prostatic Dis
Titus RS, Su J, Riveros C, Chen A, Shah HN, Satkunasivam R, Omidele O, Gonzalez RR.
PMID: 42203958 [PubMed - as supplied by publisher]


Optimizing the clinical management of prostate cancer in Taiwan: A multidisciplinary consensus.
J Formos Med Assoc
Shih-Chieh Chueh J, Cha TL, Hsueh FJ, Chen SC, Lin KJ, You BW, Zhao XJ, Yang JF, Li WI, Tsai CW, Hsu CY, Chang CH, Chen F, Said P, McMahon A.
PMID: 42203621 [PubMed - as supplied by publisher]


Reply to Tonghu Liu's Letter to the Editor re: Bacillus Calmette-Guérin Plus Mitomycin Versus Bacillus Calmette-Guérin Alone for Bacillus Calmette Guérin-naïve Non-Muscle-Invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301). Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.01.009.
Eur Urol Focus
Hayne D, Zhang AY, Thomas H, Redfern AD, Davis ID, Stockler MR.
PMID: 42203610 [PubMed - as supplied by publisher]


Re: Hayne D, Zhang AY, Thomas H, et al. Bacillus Calmette-Guérin Plus Mitomycin Versus Bacillus Calmette-Guérin Alone for Bacillus Calmette-Guérin-naïve Non-muscle-invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301). Eur Urol. In press. https://doi.org/10.1016/j.eururo.2026.01.009.
Eur Urol Focus
Liu T, Zhu C, Yan Z.
PMID: 42203609 [PubMed - as supplied by publisher]


Real-world Patterns and Trends of Intravesical Chemotherapy for Non-muscle Invasive Bladder Cancer: Insights from a Large Prospective German Cohort.
Anticancer Res
Klatte T, Hofbauer SL, Ebert J, Ecke TH.
PMID: 42203344 [PubMed - indexed for MEDLINE]


Three-factor Clinical Score for First-line Nivolumab Plus Ipilimumab in Metastatic Renal Cell Carcinoma.
Anticancer Res
Yanishi M, Nakamoto T, Yoshida T, Mishima T, Kinoshita H.
PMID: 42203341 [PubMed - indexed for MEDLINE]


Development of a Prognostic Model for Patients Aged ≤65 Years With Metastatic Renal Cell Carcinoma.
Anticancer Res
Oishi Y, Matsushita Y, Watanabe S, Watanabe K, Watanabe H, Tamura K, Motoyama D, Yanagisawa T, Mori K, Sugiyama S, Bekku K, Toyoda S, Nukaya T, Maenosono R, Komura K, Araki M, Fujita K, Takahara K, Azuma H, Inamoto T, JK-FOOT STUDY GROUP.
PMID: 42203336 [PubMed - indexed for MEDLINE]


Basaloid Urothelial Carcinoma Presenting With Paraneoplastic Hypercalcemia and Leukocytosis: A Case Report and Literature Review.
Anticancer Res
Sabbadini P, Paganoni E, Galeasso L, Depetris I, DI Maio M, Filippi R.
PMID: 42203335 [PubMed - indexed for MEDLINE]


Clinical Features and Prognostic Significance of Pulmonary Metastases in Metastatic Hormone-sensitive Prostate Cancer.
Anticancer Res
Yamada Y, Matsumoto M, Ikehara M, Tsujino T, Sato K, Saito S, Yoshikawa Y, Maenosono R, Yamamoto S, Arai T, Sato H, Higuchi K, Takei A, Kanesaka M, Ando K, Pae S, Kanaoka S, Takeshita N, Yoneda K, Hino D, Tamura T, Sazuka T, Imamura Y, Mikami K, Nakamura K, Fukasawa S, Kurozumi A, Naya Y, Nagata M, Komaru A, Tobe T, Suzuki N, Azuma H, Sakamoto S.
PMID: 42203332 [PubMed - indexed for MEDLINE]


Predictive Role of PSA Kinetics in Oncological Outcomes of Metastatic Castration-sensitive Prostate Cancer.
Anticancer Res
Yamamoto Y, Matsumura N, Fujimoto S, Morita T, Uchimoto T, Fukuokaya W, Saruta M, Sugiyama S, Tamura K, Azuma H, Kimura T, Takahara K, Komura K, Inamoto T, Fujita K.
PMID: 42203328 [PubMed - indexed for MEDLINE]


Exploration of the Challenges in the Management of Prostate Cancer in East Africa.
Clin Genitourin Cancer
Adeniyi IA, Shehu UU, Ikuomola EO, Mohammed SMA, Archibong V, Usman IM.
PMID: 42202495 [PubMed - as supplied by publisher]


Serum levels of microRNA-371a-3p (M371) for prediction of histology in chemotherapy-naïve patients with testicular germ cell tumours undergoing lymph node dissection-a retrospective analysis of 57 cases.
Urol Oncol
Dieckmann KP, Angerer M, Dumlupinar C, Fiedeldey L, Harms A, Wülfing C, Belge G.
PMID: 42202429 [PubMed - as supplied by publisher]


Micro-ultrasound as an alternative to MRI in prostate cancer biopsy: Correlation with prostatectomy findings.
Urol Oncol
Furlano K, Plage H, Hertzsprung N, Jeutner J, Mala K, Gerdes B, Weinberger S, Ralla B, Schlomm T, Reimann M.
PMID: 42202428 [PubMed - as supplied by publisher]


Multimodal Prediction of Renal Tumor Malignancy From Radiology Reports and Structured Electronic Health Records: Retrospective Cohort Study.
JMIR Med Inform
Fan Z, Liang R, Sun C, Pan J, Terry R, Xu J.
PMID: 42202288 [PubMed - indexed for MEDLINE]


Response to 'Impact of control selection strategies on GWAS results: a study of prostate cancer in the UK Biobank'.
Brief Bioinform
Law PJ, Went M, Houlston RS.
PMID: 42202284 [PubMed - in process]


Mechanisms and therapeutic implications of metabolic heterogeneity and histone lactylation in clear cell renal cell carcinoma.
Discov Oncol
Ma J, Qiang Z, Xie W, Jiao L, Wang Y, Mi L, Yang Z, Chen G.
PMID: 42201572 [PubMed - as supplied by publisher]


3D surgical navigation contributes to renal function preservation during robot-assisted partial nephrectomy.
J Robot Surg
Park MU, Suh J, Kim JK, Song C.
PMID: 42201407 [PubMed - indexed for MEDLINE]


PROQURE-I: a phase I study adding concurrent [(177)Lu]Lu-PSMA-617 to EBRT and ADT in curative intent treatment of N1 prostate cancer.
Eur J Nucl Med Mol Imaging
Zuur LG, Hoogenkamp DS, van der Sar ECA, van Asten D, Lam MGEH, van der Voort-van Zyp JRN, van Leeuwen PJ, de Wit-van der Veen BJ, de Vries-Huizing DMV, Hendrikx JJMA, Braat AJAT, Vogel WV.
PMID: 42201380 [PubMed - as supplied by publisher]


Beyond PSA-Can Systemic Inflammatory Indices Improve Prostate Cancer Detection?
Med Sci (Basel)
Iv, Shurrab A, Puia D, Iv, Corlade-Andrei M, Stoican N, Pricop C.
PMID: 42201035 [PubMed - indexed for MEDLINE]


Synchronous Prostate Adenocarcinoma and Bladder Carcinoma In Situ Detected During Evaluation of Incidental PSA Elevation: A Case Report Illustrating Multimodal Diagnostic Correlation and Long-Term Follow-Up.
Reports (MDPI)
Borta SM, Cri, Miklos I, Zdremtan D, Coman RA.
PMID: 42200870 [PubMed]


   
   Articles 1 - 20 / 188197    Page 1 of 9410  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1